Cambria Investment Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.84M Buy
5,093
+2,941
+137% +$1.01M 0.09% 207
2026
Q1
$757K Buy
2,152
+262
+14% +$93.4K 0.04% 275
2025
Q4
$619K Buy
1,890
+605
+47% +$192K 0.04% 360
2025
Q3
$363K Buy
+1,285
New +$373K 0.02% 403
2019
Q4
– Sell
-24,265
Closed -$4.7M – 182
2019
Q3
$4.7M Sell
24,265
-232
-0.9% -$44.5K 0.7% 61
2019
Q2
$4.51M Buy
24,497
+1,924
+9% +$345K 0.69% 68
2019
Q1
$4.29M Buy
22,573
+1,460
+7% +$279K 0.66% 72
2018
Q4
$4.11M Sell
21,113
-1,324
-6% -$258K 0.7% 47
2018
Q3
$4.65M Sell
22,437
-727
-3% -$143K 0.68% 43
2018
Q2
$4.43M Sell
23,164
-2,122
-8% -$375K 0.66% 52
2018
Q1
$4.31M Sell
25,286
-8,414
-25% -$1.54M 0.63% 74
2017
Q4
$5.86M Buy
33,700
+5,004
+17% +$886K 0.82% 63
2017
Q3
$5.35M Buy
28,696
+2
+0% +$354 0.82% 54
2017
Q2
$4.94M Buy
+28,694
New +$4.67M 1.06% 28
2015
Q4
– Sell
-65
Closed -$9K – 161
2015
Q3
$9K Buy
+65
New +$10.2K ﹤0.01% 280

Other funds holding AMGN

Cambria Investment Management's AMGN Position: Q2 2026 in Review

Cambria Investment Management increased its Amgen (AMGN) stake by 137% in Q2 2026, buying an estimated $1.01M and bringing the position to 5,093 shares worth $1.84M. The position accounts for 0.09% of the portfolio, ranked #207.

Cambria Investment Management first reported a position in AMGN in Q3 2015 and has held it in 15 quarters since. The position peaked at $5.86M in Q4 2017. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Cambria Investment Management held 5,093 shares of Amgen worth $1.84M as of Q2 2026.
  • Cambria Investment Management bought 2,941 Amgen shares in Q2 2026, an estimated $1.01M.
  • Amgen made up 0.09% of Cambria Investment Management's portfolio in Q2 2026, its #207 holding.
  • Cambria Investment Management first reported a position in Amgen in Q3 2015 and has held it in 15 quarters since.
  • Cambria Investment Management's Amgen position peaked at $5.86M in Q4 2017.
  • 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Cambria Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.